论文部分内容阅读
目的探讨复方丹参滴丸治疗冠状动脉粥样硬化性心脏病(CHD)合并高血压患者的临床效果。方法选取2014年1月至2015年1月黑龙江省医院收治的88例CHD合并高血压患者作为研究对象,按随机数字表法将其分为对照组和研究组,各44例。对照组患者采用硝苯地平缓释片进行治疗,研究组患者口服复方丹参滴丸,比较两组患者治疗前后血压水平、血压达标率及心脑血管事件发生情况。结果治疗后,两组患者的舒张压、收缩压水平均较治疗前有明显降低,且研究组患者的舒张压、收缩压水平均明显低于对照组,差异均有统计学意义(均P<0.05);研究组患者的心脑血管事件发生率明显低于对照组,血压达标率明显高于对照组,差异均有统计学意义(均P<0.05)。结论复方丹参滴丸能够明显降低CHD合并高血压患者心脑血管事件的发生率,有效控制血压水平,具有良好的临床作用价值。
Objective To investigate the clinical effect of Fufang Danshen Diwan on hypertensive patients with coronary atherosclerotic heart disease (CHD). Methods From January 2014 to January 2015, 88 CHD patients with hypertension complicated by hypertension admitted to Heilongjiang Provincial Hospital were enrolled in this study. According to the random number table, they were divided into control group and study group, 44 cases in each group. Patients in the control group were treated with nifedipine sustained-release tablets. Patients in the study group were given oral compound Danshen dripping pills. Blood pressure, blood pressure compliance rate and cardiovascular and cerebrovascular events were compared between the two groups before and after treatment. Results After treatment, the diastolic blood pressure and systolic blood pressure in both groups were significantly lower than those before treatment, and the diastolic blood pressure and systolic blood pressure in the study group were significantly lower than those in the control group (all P < 0.05). The incidence of cardiovascular and cerebrovascular events in study group was significantly lower than that in control group, and the blood pressure compliance rate was significantly higher than that in control group (all P <0.05). Conclusion Compound Danshen Dripping Pills can significantly reduce the incidence of cardiovascular and cerebrovascular events in CHD patients with hypertension, and effectively control blood pressure, which has a good clinical value.